Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy

Arthritis Rheumatol. 2021 Jan;73(1):173-174. doi: 10.1002/art.41472. Epub 2020 Dec 5.

Authors

Elena Gkrouzman¹, Medha Barbhaiya¹, Doruk Erkan¹, Michael D Lockshin¹

Affiliation

¹ Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.

PMID: 32901454
DOI: 10.1002/art.41472

No abstract available

Publication types

Letter
Review

MeSH terms

Antibodies, Anticardiolipin / immunology
Antibodies, Antiphospholipid / immunology*
Antiphospholipid Syndrome / blood
Antiphospholipid Syndrome / diagnosis*
Antiphospholipid Syndrome / immunology
COVID-19 / blood
COVID-19 / immunology*
Humans
Immunoglobulin M / immunology
Lupus Coagulation Inhibitor / immunology
SARS-CoV-2
Thrombophilia / blood
Thrombophilia / immunology*
Thrombosis / blood
Thrombosis / immunology
beta 2-Glycoprotein I / immunology

Substances

Antibodies, Anticardiolipin
Antibodies, Antiphospholipid
Immunoglobulin M
Lupus Coagulation Inhibitor
beta 2-Glycoprotein I